JP2014524903A5 - - Google Patents

Download PDF

Info

Publication number
JP2014524903A5
JP2014524903A5 JP2014516148A JP2014516148A JP2014524903A5 JP 2014524903 A5 JP2014524903 A5 JP 2014524903A5 JP 2014516148 A JP2014516148 A JP 2014516148A JP 2014516148 A JP2014516148 A JP 2014516148A JP 2014524903 A5 JP2014524903 A5 JP 2014524903A5
Authority
JP
Japan
Prior art keywords
protein
pharmaceutical composition
chimeric
gpcr
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014516148A
Other languages
English (en)
Japanese (ja)
Other versions
JP6240067B2 (ja
JP2014524903A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CH2012/000138 external-priority patent/WO2012174674A1/en
Publication of JP2014524903A publication Critical patent/JP2014524903A/ja
Publication of JP2014524903A5 publication Critical patent/JP2014524903A5/ja
Application granted granted Critical
Publication of JP6240067B2 publication Critical patent/JP6240067B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014516148A 2011-06-24 2012-06-22 光感受性キメラgpcrタンパク質 Active JP6240067B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161500863P 2011-06-24 2011-06-24
US61/500,863 2011-06-24
PCT/CH2012/000138 WO2012174674A1 (en) 2011-06-24 2012-06-22 Light-sensitive chimeric gpcr protein

Publications (3)

Publication Number Publication Date
JP2014524903A JP2014524903A (ja) 2014-09-25
JP2014524903A5 true JP2014524903A5 (https=) 2017-11-02
JP6240067B2 JP6240067B2 (ja) 2017-11-29

Family

ID=46456289

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014516148A Active JP6240067B2 (ja) 2011-06-24 2012-06-22 光感受性キメラgpcrタンパク質

Country Status (19)

Country Link
US (1) US10112984B2 (https=)
EP (2) EP3029063B1 (https=)
JP (1) JP6240067B2 (https=)
KR (1) KR102008538B1 (https=)
CN (2) CN103814045B (https=)
AU (1) AU2012272505B2 (https=)
BR (2) BR112013033028A8 (https=)
CA (1) CA2840458C (https=)
DK (1) DK3029063T3 (https=)
ES (1) ES2766398T3 (https=)
HR (1) HRP20200004T1 (https=)
HU (1) HUE047074T2 (https=)
LT (1) LT3029063T (https=)
PL (2) PL2723767T3 (https=)
PT (1) PT3029063T (https=)
RU (1) RU2637367C2 (https=)
SI (1) SI3029063T1 (https=)
WO (1) WO2012174674A1 (https=)
ZA (1) ZA201308824B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140087463A1 (en) * 2012-09-25 2014-03-27 The Washington University Optical control of cell signaling
EP3007730A1 (en) 2013-06-11 2016-04-20 Friedrich Miescher Institute for Biomedical Research Retinal on bipolar cells-specific artificial promoter
GB201403260D0 (en) 2014-02-25 2014-04-09 Univ Manchester Treatment of retinal degeneration using gene therapy
JP6779546B2 (ja) * 2016-11-06 2020-11-04 ナノスコープ テクノロジーズ エルエルシーNanoscope Technologies Llc 視力回復のための多特性オプシンによる光遺伝学的調節及びその別の用途
EP3318285A1 (en) * 2016-11-08 2018-05-09 Oxford University Innovation Limited Treatment of eye disease
MX2020004643A (es) * 2017-11-13 2021-01-29 Univ California Composiciones y metodos para mejorar la funcion visual.
EP3735572A1 (en) * 2018-01-02 2020-11-11 Signify Holding B.V. Light melanopic activity indicator
WO2020221769A1 (en) 2019-04-29 2020-11-05 Confo Therapeutics N.V. Screening methods and assays for use with transmembrane proteins, in particular with gpcrs
CN114729009A (zh) 2019-10-31 2022-07-08 伯尔尼大学 用于眼部基因递送的aav载体变体
US20240174743A1 (en) * 2019-11-29 2024-05-30 Universität Bern Chimeric opsin gpcr proteins
WO2021140205A1 (en) * 2020-01-10 2021-07-15 Confo Therapeutics N.V. Methods for generating antibodies and antibody fragments and libraries comprising same
CN114762723A (zh) * 2020-12-31 2022-07-19 吴伯骥 HrpZpst蛋白在识别激活多类受体和/或膜蛋白及其信号通路的制药中的应用
CN112675293A (zh) * 2020-12-31 2021-04-20 吴伯骥 HrpNEcb蛋白在识别激活多类受体和/或膜蛋白及其信号通路的制药中的应用
JP2025519378A (ja) * 2022-06-07 2025-06-26 アドヴェラム バイオテクノロジーズ, インコーポレイテッド 視覚回復のためのメラノプシンバリアント
CN118791624B (zh) * 2023-04-11 2026-04-03 苏州星明优健生物技术有限公司 用于治疗视网膜神经退行性疾病的新型gpcr嵌合视蛋白
WO2026017073A1 (zh) * 2024-07-16 2026-01-22 北京脑科学与类脑研究所 一种光敏蛋白及其应用
CN120442622A (zh) * 2024-09-23 2025-08-08 中眸医疗科技(武汉)有限公司 多种在on型双极细胞上高效靶定的启动子在基因治疗技术中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2308779T3 (es) * 1995-07-26 2008-12-01 Astrazeneca Ab Receptores quimericos y metodos para identificar compuestos activos en los receptores de glutamato metabotropico y el uso de tales compuestos en el tratamiento de trastornos y enfermedades neurologicas.
WO2004009022A2 (en) 2002-07-18 2004-01-29 The General Hospital Corp. Method for augmenting vision in persons suffering from photoreceptor cell degeneration
GB0426196D0 (en) 2004-11-30 2004-12-29 Imp College Innovations Ltd Methods of treatment
CN101484005A (zh) 2006-05-04 2009-07-15 韦恩州立大学 通过向体内递送视紫红质核酸恢复视觉响应
EP1891976A1 (en) 2006-08-23 2008-02-27 Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute for Biomedical Research Use of light sensitive genes
US8178496B2 (en) * 2007-12-21 2012-05-15 The Regents Of The University Of California Photoreactive regulator of glutamate receptor function and methods of use thereof
WO2010011404A2 (en) * 2008-05-20 2010-01-28 Eos Neuroscience, Inc. Vectors for delivery of light-sensitive proteins and methods of use
RU2374245C1 (ru) * 2008-08-22 2009-11-27 Андрей Александрович Иващенко Лиганд с широким спектром одновременной рецепторной активности, фармацевтическая композиция, способ ее получения и лекарственное средство
NZ602416A (en) * 2008-11-14 2014-08-29 Univ Leland Stanford Junior Optically-based stimulation of target cells and modifications thereto

Similar Documents

Publication Publication Date Title
JP2014524903A5 (https=)
RU2014101708A (ru) Светочувствительный химерный белок gpcr
ES3008567T3 (en) Recombinant antibody molecule and its use for target cell restricted t cell activation
ES2883633T3 (es) Agentes terapéuticos
Okada et al. Activation of rhodopsin: new insights from structural and biochemical studies
US10428149B2 (en) Single-chain tumor necrosis factor (TNF) ligand family molecules, fusion proteins and derivatives thereof
ES2613523T3 (es) Antagonistas de ActRIIb y dosificación y usos de los mismos
JP2020508068A5 (https=)
TW201141509A (en) Modified binding proteins inhibiting the VEGF-A receptor interaction
WO2010105573A1 (zh) 抗血管新生融合蛋白
CN109715658B (zh) 可溶性成纤维细胞生长因子受体3(sfgfr3)多肽及其用途
JP2015518479A5 (https=)
JP2016510755A5 (https=)
CA3162568A1 (en) Chimeric opsin gpcr proteins
JP6757024B2 (ja) 視覚機能再生剤又は視覚機能低下予防剤
AU2016232819B2 (en) Compositions and methods for use of anion channel rhodopsins
JP2025123277A (ja) キメラロドプシンをコードする核酸コンストラクト
WO2020148913A1 (ja) 網膜疾患の予防および進行抑制、視覚認知行動機能の改善、および視覚機能強化
KR102618373B1 (ko) 키메라성 클로로톡신 수용체
CN103930439A (zh) 基因工程生长因子变异体
CN109996817A (zh) 扭转原肠胚形成多肽及其用途
JP7054143B2 (ja) キメラ抗原受容体、及びその利用
WO2022192259A1 (en) BIFUNCTIONAL HOMODIMERIC ANTI-PD-1 AND IL-15/IL-15Rα FUSION PROTEINS AND USES THEREOF
KR20250061742A (ko) 광응답 변형 옵신
WO2016014725A1 (en) Molecular constructs and uses thereof